NDC 70518-3512-07 - Ondansetron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3512
- Requested NDC
- 70518-3512-07
- Package NDCs from labels
- 70518-3512-0, 70518-3512-1, 70518-3512-2, 70518-3512-3, 70518-3512-4, 70518-3512-5, 70518-3512-6, 70518-3512-7, 70518-3512-8, 70518-3512-07
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ondansetron - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3512-0 | Ondansetron | 30 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 30 | 13 | |
| 70518-3512-1 | Ondansetron | 6 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 6 | 13 | |
| 70518-3512-2 | Ondansetron | 10 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | 13 | |
| 70518-3512-3 | Ondansetron | 20 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 20 | 13 | |
| 70518-3512-4 | Ondansetron | 12 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 12 | 13 | |
| 70518-3512-5 | Ondansetron | 9 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 9 | 13 | |
| 70518-3512-6 | Ondansetron | 21 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 21 | 13 | |
| 70518-3512-7 | Ondansetron | 15 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 15 | 13 | |
| 70518-3512-8 | Ondansetron | 3 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 3 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3512 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [REMEDYREPACK INC.] | 7 | Current NDC, Legacy NDC, 9 package rows | 20250313_c0d827d0-333f-4187-ac75-9dc7d34b6169.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70518-3512-0 | EA - Each | 70518-3512 | c09bb726-6922-454a-85e3-77953f31aaa8 | 1 | 2026-01-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 9c3ad9c1-474e-4331-a017-09cec46702d8 | 2026-11-05 | Warnings, Adverse reactions | ANDA078152 312087 4AF302ESOS |
| ONDANSETRON HYDROCHLORIDE | ONDANSETRON HYDROCHLORIDE | Cardinal Health 107, LLC | 30107d6f-5128-484f-b713-65244a98dc67 | 2026-11-03 | Warnings, Adverse reactions | NMH84OZK2B |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2026-11-02 | Warnings, Adverse reactions | 3OWL53L36A |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | ee1f115f-c8f8-4526-b827-c8e48aeb5050 | 2026-10-27 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | c0d827d0-333f-4187-ac75-9dc7d34b6169 | 2026-10-26 | Warnings, Adverse reactions | ANDA078152 70518-3512-6 70518-3512-5 70518-3512-2 70518-3512-7 70518-3512-1 70518-3512-3 70518-3512-4 70518-3512-8 70518-3512-0 70518-3512 70518351207 104894 5ebf5cd9-dfd7-57ee-e063-6294a90a7f1e c0d827d0-333f-4187-ac75-9dc7d34b6169 4AF302ESOS |
| Ondansetron | ONDANSETRON | Sportpharm LLC | 3c4cda2f-13d9-42c5-b449-77deb06c8de5 | 2026-10-22 | Warnings, Adverse reactions | 312087 4AF302ESOS |
| ONDANSETRON | ONDANSETRON | Henry Schein, Inc. | 1a44601b-c31c-4779-a688-28cc4cc75e8b | 2026-10-19 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 426ba54f-199a-41d1-8c27-f827bea56854 | 2026-10-14 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | A-S Medication Solutions | 674ea285-8f84-4603-9655-82200c523fe5 | 2026-10-12 | Warnings, Adverse reactions | 312086 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Cardinal Health 107, LLC | 61758670-91ab-4422-8d9d-e8ca87eecae8 | 2026-10-12 | Warnings, Adverse reactions | NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 14276805-4e99-4bbe-ad76-ffc06eddb38a | 2026-10-09 | Warnings, Adverse reactions | 312086 198052 NMH84OZK2B |
| Ondansetron Hydrochloride | ONDANSETRON HYDROCHLORIDE | REMEDYREPACK INC. | 960e2104-18c3-4cfa-abf6-f1b30c452918 | 2026-10-05 | Warnings, Adverse reactions | 198052 NMH84OZK2B |
| Ondansetron | ONDANSETRON | Asclemed USA, Inc. | 269c920c-643a-4eea-9bf9-b1f008915db9 | 2026-10-01 | Warnings, Adverse reactions | 104894 4AF302ESOS |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | ETJ7Z6XBU4 |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | ETJ7Z6XBU4 |
| Ondansetron | ONDANSETRON | REMEDYREPACK INC. | 416be720-82e8-4a6d-8531-c1a29869daae | 2026-09-01 | Warnings, Adverse reactions | 312086 NMH84OZK2B |
| BMNP Silicea | SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5a58454f-aed6-24ba-e063-6294a90a47fb | 2026-08-31 | Warnings | ETJ7Z6XBU4 |
| Argentum Quartz | ARGENTUM QUARTZ | Uriel Pharmacy Inc. | 765c8c8f-0727-45da-a77e-c3907a3d0793 | 2026-08-26 | Warnings | ETJ7Z6XBU4 |
| Endometrium Argentum | ENDOMETRIUM ARGENTUM | Uriel Pharmacy Inc | d2d1428a-c8b5-9529-e053-2995a90a2343 | 2026-08-26 | Warnings | ETJ7Z6XBU4 |
| Ondansetron | ONDANSETRON | St. Mary's Medical Park Pharmacy | f175a336-433b-7ab2-e053-2995a90ad5ca | 2026-08-26 | Warnings, Adverse reactions | ANDA078152 104894 4AF302ESOS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.